AMGEN INC Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Amgen Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q3 2024.
  • Amgen Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.83B, a 167% increase year-over-year.
  • Amgen Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.69B, a 28.5% decline year-over-year.
  • Amgen Inc annual Nonoperating Income (Expense) for 2023 was $2.83B.
  • Amgen Inc annual Nonoperating Income (Expense) for 2022 was -$814M, a 414% decline from 2021.
  • Amgen Inc annual Nonoperating Income (Expense) for 2021 was $259M, a 1.17% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.69B $1.83B +$1.15B +167% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $545M -$307M +$11M +3.46% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $534M -$235M -$2.3B -111% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $2.83B $402M +$469M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $2.36B $685M +$585M +585% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.78B -$318M -$1M -0.32% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.78B $2.06B +$2.59B Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 -$814M -$67M -$229M -141% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 -$585M $100M +$27M +37% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 -$612M -$317M -$328M -2982% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$284M -$530M -$543M -4177% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $259M $162M -$25M -13.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $284M $73M +$18M +32.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $266M $11M +$8M +267% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $258M $13M +$2M +18.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $256M $187M -$49M -20.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $305M $55M -$59M -51.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $364M $3M -$215M -98.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $579M $11M -$174M -94.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $753M $236M +$81M +52.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $672M $114M -$12M -9.52% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $684M $218M +$56M +34.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $628M $185M -$46M -19.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $674M $155M -$146M -48.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $820M $126M -$141M -52.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $961M $162M -$3M -1.82% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $964M $231M +$36M +18.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $928M $301M +$175M +139% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $753M $267M +$51M +23.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $702M $165M +$28M +20.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $674M $195M +$45M +30% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $629M $126M -$38M -23.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $667M $216M +$81M +60% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $586M $137M -$61M -30.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $647M $150M +$44M +41.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $603M $164M +$76M +86.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $527M $135M -$5M -3.57% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $532M $198M +$60M +43.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $472M $106M +$7M +7.07% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $465M $88M $0 0% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $465M $140M +$68M +94.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $397M $138M +$42M +43.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $355M $99M -$65M -39.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $420M $88M -$38M -30.2% Oct 1, 2013 Dec 31, 2013 8-K 2016-10-31
Q3 2013 $458M $72M -$39M -35.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $497M $96M -$28M -22.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $525M $164M +$40M +32.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $485M $126M +$42M +50% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $443M $111M +$24M +27.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $419M $124M -$5M -3.88% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $424M $124M -$24M -16.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $448M $84M -$9M -9.68% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $457M $87M -$18M -17.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $475M $129M +$35M +37.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $440M $148M +$64M +76.2% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $376M $93M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $105M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $94M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $84M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.